Related Experiment Video

Updated: Jul 17, 2026

Protein Target Prediction and Validation of Small Molecule Compound
10:21

Protein Target Prediction and Validation of Small Molecule Compound

Published on: February 23, 2024

1. Molecular target drug discovery

Fumihiko Kimura1

  • 1Department of Internal Medicine, Division of Hematology, National Defense Medical College, Saitama. fkimura@ndmc.ac.jp

Internal Medicine (Tokyo, Japan)
|January 16, 2007
PubMed

Insights

Cancer arises from genetic mutations. Molecularly targeted drugs offer specific cancer treatments by targeting abnormal genes and proteins, but their effectiveness requires predictive diagnostics like DNA microarrays.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Cancer develops due to genetic abnormalities, including oncogene activation and tumor suppressor gene inactivation.
  • Current treatments lack effective genomic correction techniques.
  • Molecular analyses reveal cancer-specific targets like abnormal gene products, signaling pathways, and cell surface antigens.

Purpose of the Study:

  • To review the development and application of molecularly targeted drugs in cancer treatment.
  • To highlight the specificity and potential limitations of these targeted therapies.
  • To emphasize the need for predictive diagnostics in guiding treatment decisions.

Main Methods:

  • Review of molecular biological analyses identifying cancer-specific targets.
  • Description of molecularly targeted drugs designed to inhibit specific molecules (mRNA, protein).
  • Discussion of the role of host cell targets, such as angiogenic factor receptors.

Main Results:

  • Molecularly targeted drugs exhibit higher specificity for cancer cells compared to conventional chemotherapy.
  • These drugs can suppress key molecules essential for cancer maintenance.
  • Some targeted therapies may stabilize tumors rather than eliminate them.
  • Targeted drug efficacy is dependent on target expression and functional importance in cancer.

Conclusions:

  • Molecularly targeted drugs represent a significant advancement in cancer therapy due to their specificity.
  • Predictive molecular techniques, such as DNA microarrays, are crucial for determining appropriate patient selection and optimizing treatment outcomes.
  • Further research is needed to refine genomic correction strategies and enhance the efficacy of targeted therapies.

More Related Videos

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.